July 30, 2014 11:23 AM ET

Life Sciences Tools and Services

Company Overview of Furiex Pharmaceuticals, Inc.

Executive Profile

Wendy L. Dixon Ph.D.

Director and Chairman of Nominating & Corporate Governance Committee, Alkermes plc
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 9 different industries.

See Board Relationships
59$489,651

Background

Dr. Wendy L. Dixon, Ph.D. served as the Chief Marketing Officer and President of Global Marketing at Worldwide Medicines Pharmaceuticals Group, a division of Bristol-Myers Squibb Company from December 2001 to May 2009. Dr. Dixon was responsible for leading Global Marketing to commercialize new products and to determine the lifecycle strategy of the in-line growth brands of Bristol-Myers. She has a 34 year career in the pharmaceutical and biotechnology business, combining ...

Corporate Headquarters

3900 Paramount Parkway
Morrisville, North Carolina 27560

United States

Phone: 919-456-7800
Fax: --

Board Members Memberships

2005-2010
Former Independent Director and Member of Human Resources Committee
2010-Present
Director and Member of Audit Committee
2010-Present
Director, Member of Audit Committee and Member of Compensation Committee
2010-Present
Director, Chairman of Nominating & Governance Committee, Member of Audit Committee and Member of Compensation Committee
2011-Present
Director and Chairman of Nominating & Corporate Governance Committee
2011-Present
Director, Member of Nominating & Corporate Governance Committee and Member of Commercial Committee
2013-Present
Director and Member of Audit Committee
2013-Present
Independent Director

Education

MS
University of Cambridge
PhD
University of Cambridge
BS
University of Cambridge

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$64,243
Total Calculated Compensation$489,651
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
$916.2K
Carolyn J. Logan Chief Executive Officer, President and Director
Salix Pharmaceuticals Ltd.
$867.5K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Alessandro E. Della Chà LL.MChief Executive Officer and Director
Cosmo Pharmaceuticals S.p.A.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Furiex Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.